サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1747898

放射性トレーサーの世界市場

Radioactive Tracers

出版日
ページ情報
英文 249 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
放射性トレーサーの世界市場
出版日: 2025年06月13日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 249 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

放射性トレーサーの世界市場は2030年までに56億米ドルに到達

2024年に37億米ドルと推定される放射性トレーサーの世界市場は、2024年から2030年にかけてCAGR 7.0％で成長し、2030年には56億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである診断放射性トレーサーは、CAGR 8.0％を記録し、分析期間終了までに37億米ドルに達すると予測されます。治療用放射性トレーサー分野の成長率は、分析期間中CAGR 4.8%と推定されます。

米国市場は9億8,480万米ドルと推定、中国はCAGR 6.7％で成長すると予測

米国の放射性トレーサー市場は、2024年に9億8,480万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.7%として、2030年までに8億9,780万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.6%と5.8%と予測されています。欧州では、ドイツがCAGR 5.5%で成長すると予測されています。

世界の「放射性トレーサー」市場- 主要動向と促進要因のまとめ

放射性トレーサーは精密診断と産業発見を支える見えざるヒーローか？

放射性トレーサーは、ニッチな科学的ツールから、医療と産業の両分野で不可欠な資産へと変貌を遂げました。ヘルスケアでは、これらの同位体化合物は核医学において極めて重要であり、PET（陽電子放射断層撮影）やSPECT（単光子放射断層撮影）のようなイメージング・モダリティを通じて、生理学的プロセスをリアルタイムで可視化するために使用されています。この機能により、がん、心血管疾患、神経疾患などの病気の早期発見が可能になり、治療成績が大幅に向上します。医療にとどまらず、放射性トレーサーは、パイプラインの漏水検知、地下水の流れのマッピング、複雑な製造工程における化学反応のモニタリングなど、産業用途においても重要な役割を果たしています。微量の物質を極めて正確に追跡することができるため、精度が要求される環境では非常に重宝されます。規制機関や学術機関は、半減期が短く安全性が改善された新しいアイソトープの研究を拡大し続けており、より広範な応用が可能になっています。放射性トレーサーは、最小限の侵襲性と最大限の洞察力により、生物科学と物理科学におけるデータ収集方法に革命をもたらし、その価値を現代のイノベーションにしっかりと定着させています。

なぜ同位体生産の進歩がトレーサーを取り巻く環境を変えるのか？

放射性トレーサーを取り巻くエコシステム全体は、アイソトープ生産技術の進歩によって著しく向上しました。従来は原子炉に依存していたトレーサー・アイソトープ生産は、高出力サイクロトロンやリニア加速器によって補完されるようになってきています。これらの施設は、フッ素18、テクネチウム99m、ガリウム68など、PETやSPECT診断に広く使用されているアイソトープを、局所的にオンデマンドで生成することを可能にします。アイソトープ製造の分散化により、国際的な原子炉施設への依存度が下がり、物流のボトルネックや輸送中のアイソトープ崩壊が最小限に抑えられました。さらに、新しい放射化学技術はトレーサーの収率、純度、安定性を向上させ、イメージング性能と患者の安全性を高めています。放射性医薬品合成の自動化により、病院や画像診断センターが院内で投与量を調製できるようになり、治療までの時間が短縮され、特定の臨床ニーズに基づいて製剤をカスタマイズできるようになりました。産業環境においては、放射性同位元素トレーシング材料は、過酷な環境においてより高い耐久性と精度を発揮するように設計されています。これらのブレークスルーは、現在のアプリケーションを最適化するだけでなく、個別化医療、農薬研究、先端材料分析などの新たな分野にもトレーサー使用を拡大しています。生産技術がより洗練されるにつれて、トレーサー使用におけるアクセシビリティ、効率性、革新性は新たな高みへとスケールアップしています。

拡大する臨床・産業用途は長期的な市場の勢いを維持できるか？

放射性トレーサーの用途はかつてないほど多様化しており、これは長期的な市場の勢いを維持する上で重要です。臨床環境においては、ルテチウムは診断のみならず、同じ放射性標識薬剤を用いた画像診断と標的治療の融合であるセラノシス応用にも不可欠なものとなっています。例えば、ルテチウム-177は、前立腺がんや神経内分泌腫瘍の治療において、同時に診断が可能であることから注目を集めています。心臓病学では、ルビジウム82のようなトレーサーが心筋灌流のリアルタイム評価を強化しています。産業界では、土壌浸食、土砂輸送、汚染物質の拡散を調査するための環境モニタリングにおいて、トレーサーの利用が増加しています。石油・ガス分野では、貯留層の特性評価や増進回収プロセスにトレーサーを使用しています。さらに、食品と農業の研究者は、作物における栄養分の取り込みを評価し、農薬の吸収をモニターするためにトレーサーを利用しています。薬剤開発におけるトレーサーの有用性、特に薬物動態学と生体内分布研究は、もう一つの急成長分野です。各分野で精度の要求が高まるにつれ、放射性同位元素の本質的なトレーサビリティは、比類のないツールとして位置づけられています。このような最終用途の拡大は、一貫した需要を生み出すだけでなく、トレーサー技術が中心的な役割を果たす学際的イノベーションを促進しています。

放射性トレーサー市場の絶え間ない成長の原動力は？

放射性トレーサー市場の成長は、技術的進化、最終用途の拡大、業務効率に関連するいくつかの要因によって牽引されています。技術的には、同位体合成、小型サイクロトロン開発、自動放射性標識システムの革新により、トレーサーの入手性、一貫性、安全性が大幅に向上しました。ヘルスケアにおいては、慢性疾患、特にがんや心血管疾患の罹患率の増加により、放射性トレーサーが独自に提供する早期診断ツールに対する需要が高まっています。PET/CTやPET/MRIのようなハイブリッドイメージングシステムへのトレーサーの統合は、精密医療におけるトレーサーの採用をさらに後押ししています。産業分野では、持続可能な実践と効率的な資源管理の推進により、トレーサーは流量分析、漏れの検出、プロセスの最適化において貴重な存在となっています。政府や民間機関による核医学への資金提供の増加と放射性医薬品研究開発への投資の増加が、商業規模の技術革新を後押ししています。健康意識の高まりが非侵襲的診断手技の導入を後押ししているように、消費者行動動向も一役買っています。さらに、迅速な承認や安全基準の世界の調和といった規制当局の支援により、新しいトレーサー製剤の円滑な市場参入が可能となっています。これらの市場促進要因が相まって、臨床と産業の両分野で、放射性トレーサーの世界市場は堅調に拡大しています。

セグメント

タイプ（診断用放射性トレーサー、治療用放射性トレーサー、その他のタイプ）、用途（腫瘍学、心臓病学、神経学、甲状腺、整形外科、内分泌学、その他の用途）、エンドユーザー（病院、専門クリニック、診断センター、学術・研究機関、その他のエンドユーザー）

調査対象企業の例（注目の合計48社）

  • ABX Advanced Biochemical Compounds
  • Advanced Accelerator Applications
  • Bayer AG
  • Blue Earth Diagnostics
  • Bracco Imaging
  • Cardinal Health
  • Curium
  • DuChemBio Co., Ltd.
  • Eckert & Ziegler
  • GE HealthCare
  • IBA Radiopharma Solutions
  • Invicro LLC
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • Mallinckrodt Nuclear Medicine LLC
  • Nordion（Canada）Inc.
  • NorthStar Medical Radioisotopes LLC
  • NTP Radioisotopes
  • Siemens Healthineers
  • Telix Pharmaceuticals Limited

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP35635

Global Radioactive Tracers Market to Reach US$5.6 Billion by 2030

The global market for Radioactive Tracers estimated at US$3.7 Billion in the year 2024, is expected to reach US$5.6 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Diagnostic Radioactive Tracers, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Therapeutic Radioactive Tracers segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$984.8 Million While China is Forecast to Grow at 6.7% CAGR

The Radioactive Tracers market in the U.S. is estimated at US$984.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$897.8 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global "Radioactive Tracers" Market - Key Trends & Drivers Summarized

Are Radioactive Tracers The Invisible Heroes Powering Precision Diagnostics And Industrial Discovery?

Radioactive tracers have transformed from a niche scientific tool to an indispensable asset across both the medical and industrial sectors. In healthcare, these isotopic compounds are pivotal in nuclear medicine, where they are used to visualize physiological processes in real time through imaging modalities like PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography). This capability enables early detection of diseases such as cancer, cardiovascular disorders, and neurological conditions, improving treatment outcomes significantly. Beyond medicine, radioactive tracers play a critical role in industrial applications like leak detection in pipelines, mapping underground water flows, and monitoring chemical reactions in complex manufacturing processes. Their ability to track minute quantities of substances with exceptional accuracy makes them invaluable in environments where precision is non-negotiable. Regulatory agencies and academic institutions continue to expand research into newer isotopes with lower half-lives and improved safety profiles, making them more viable for broader applications. With minimal invasiveness and maximum insight, radioactive tracers are revolutionizing how data is gathered in the biological and physical sciences alike, anchoring their value firmly in modern innovation.

Why Are Advancements In Isotope Production Reshaping The Tracer Landscape?

The entire ecosystem surrounding radioactive tracers has been significantly elevated by advancements in isotope production technologies. Traditionally reliant on nuclear reactors, tracer isotope production is increasingly being supplemented by high-output cyclotrons and linear accelerators. These facilities allow for localized, on-demand generation of isotopes such as fluorine-18, technetium-99m, and gallium-68, which are widely used in PET and SPECT diagnostics. The decentralization of isotope production has reduced dependency on international reactor facilities, minimizing logistical bottlenecks and isotope decay during transit. Additionally, new radiochemistry techniques have improved the yield, purity, and stability of tracers, enhancing both their imaging performance and patient safety. Automation in radiopharmaceutical synthesis is allowing hospitals and imaging centers to prepare doses in-house, reducing time to treatment and customizing formulations based on specific clinical needs. In industrial settings, radioisotope tracing materials are being engineered for greater durability and precision in harsh environments. These breakthroughs are not only optimizing current applications but also expanding tracer use into emerging areas such as personalized medicine, agrochemical research, and advanced material analysis. As production technologies grow more sophisticated, accessibility, efficiency, and innovation in tracer use are scaling to new heights.

Can Expanding Clinical And Industrial Applications Sustain Long-Term Market Momentum?

Radioactive tracers are experiencing unprecedented diversification in their applications, which is instrumental in sustaining long-term market momentum. In clinical environments, they are now integral not only for diagnosis but also for theranostic applications-where diagnostic imaging and targeted therapy converge using the same radiolabeled agent. For instance, lutetium-177 is gaining ground in treating prostate cancer and neuroendocrine tumors with simultaneous diagnostic capability. In cardiology, tracers like rubidium-82 are enhancing real-time assessment of myocardial perfusion. Industrially, tracers are increasingly being utilized in environmental monitoring to study soil erosion, sediment transport, and pollutant dispersion. The oil and gas sector uses them for reservoir characterization and enhanced recovery processes. Moreover, food and agriculture researchers deploy radioactive tracers to evaluate nutrient uptake in crops and monitor pesticide absorption. The utility of tracers in drug development-especially in pharmacokinetics and biodistribution studies-is another burgeoning area. As precision requirements rise across disciplines, the inherently traceable nature of radioisotopes positions them as unmatched tools. This expansion of end-uses is not only generating consistent demand but also fostering interdisciplinary innovation where tracer technology plays a central role.

What’s Fueling The Relentless Growth In The Radioactive Tracers Market?

The growth in the radioactive tracers market is driven by several factors related to technological evolution, end-use expansion, and operational efficiency. Technologically, innovations in isotope synthesis, miniaturized cyclotron development, and automated radiolabeling systems have significantly enhanced tracer availability, consistency, and safety. In healthcare, the rising incidence of chronic diseases-particularly cancer and cardiovascular disorders-has escalated demand for early diagnostic tools that radioactive tracers uniquely provide. The integration of tracers into hybrid imaging systems like PET/CT and PET/MRI is further boosting their adoption in precision medicine. In industrial domains, the push for sustainable practices and efficient resource management has made tracers invaluable in flow analysis, leak detection, and process optimization. Increased funding in nuclear medicine by governments and private institutions, along with growing investments in radiopharmaceutical R&D, are propelling commercial-scale innovation. Consumer behavior trends also play a part, as rising health awareness encourages uptake of non-invasive diagnostic procedures. Additionally, regulatory support in terms of expedited approvals and global harmonization of safety standards is enabling smoother market entry for new tracer formulations. Collectively, these drivers are shaping a robust and expanding global market for radioactive tracers across both clinical and industrial verticals.

SCOPE OF STUDY:

The report analyzes the Radioactive Tracers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, Other Types); Application (Oncology, Cardiology, Neurology, Thyroid, Orthopedic, Endocrinology, Other Applications); End-User (Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

  • ABX Advanced Biochemical Compounds
  • Advanced Accelerator Applications
  • Bayer AG
  • Blue Earth Diagnostics
  • Bracco Imaging
  • Cardinal Health
  • Curium
  • DuChemBio Co., Ltd.
  • Eckert & Ziegler
  • GE HealthCare
  • IBA Radiopharma Solutions
  • Invicro LLC
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • Mallinckrodt Nuclear Medicine LLC
  • Nordion (Canada) Inc.
  • NorthStar Medical Radioisotopes LLC
  • NTP Radioisotopes
  • Siemens Healthineers
  • Telix Pharmaceuticals Limited

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Radioactive Tracers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cancer and Chronic Diseases Drives Clinical Adoption of Radioactive Tracers
    • Technological Advances in PET and SPECT Imaging Strengthen Demand for Precision Tracers
    • Expansion of Nuclear Medicine Infrastructure Globally Sustains Supply and Demand Growth
    • Government Support for Diagnostic Imaging and Radiopharmaceutical R&D Spurs Innovation
    • Growing Use of Tracers in Personalized Medicine and Targeted Therapy Expands Clinical Relevance
    • Aging Population and Early Diagnosis Trends Accelerate Use of Diagnostic Tracers
    • Supply Chain Constraints and Short Half-Life of Isotopes Present Logistical Challenges
    • Partnerships Between Hospitals and Radiopharmacies Strengthen Distribution Models
    • Rising Research in Neurology and Cardiology Imaging Drives Diversification of Tracer Applications
    • Increasing Regulatory Approvals for Novel Tracers Expand the Therapeutic Toolbox
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Radioactive Tracers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Radioactive Tracers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Diagnostic Radioactive Tracers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Therapeutic Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Therapeutic Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Therapeutic Radioactive Tracers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Thyroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Thyroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Thyroid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Orthopedic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Endocrinology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • JAPAN
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • CHINA
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • EUROPE
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Radioactive Tracers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Radioactive Tracers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • FRANCE
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • GERMANY
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 125: UK Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 131: UK Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: UK 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of World 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of World Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of World Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of World 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of World Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of World Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of World 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION